Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 10Gastrointestinal 6Head & Neck 5Thoracic 3Sarcoma 2Lymphoid 2Classical hematology 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 38Anemia, Refractory, with Excess of Blasts 31Venous Thromboembolism 23Myelodysplastic Syndromes 21Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia 15Anemia, Aplastic 14Thrombocytopenia 11Lymphoma 11Lymphoma, Non-Hodgkin 10Leukemia, Myelomonocytic, Chronic 10Anemia 10Myeloproliferative Disorders 9Primary Myelofibrosis 8Multiple Myeloma 8Hodgkin Disease 8Hematologic Neoplasms 8Cytopenia 8Anemia, Sickle Cell 8Venous Thrombosis 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Febrile Neutropenia 7Congenital Bone Marrow Failure Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia, Biphenotypic, Acute 6Fanconi Anemia 6Bone Marrow Failure Disorders 6beta-Thalassemia 5Pulmonary Embolism 5

Interventions

Tretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Classical hematology × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡